Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
NA
The primary objective of the study is to assess the safety and the efficacy...
Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion
N/A
The OCEAN (long-term mOn-antiplatelet drug strategy after perCutanEous coro...
Status
Unknown
Location
The First People's Hospital of Shunde
Start Date
2018-10-15
Trial ID
NCT03725800
Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
PHASE3
This is a single-centre, open-label prospective randomized pharmacodynamic ...